Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Aprea Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −1 vs. Q3 2023
- Shares held
- 926.9K
- +49.5K (+5.6%) vs. Q3 2023
- Total value
- $4.36M
- +$694.8K (+19.0%) vs. Q3 2023
- New holders
- 1
- 6 more added
- Sold out
- 2
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.90M |
| Q1 2026 | 22 | $1.71M |
| Q4 2025 | 22 | $1.45M |
| Q3 2025 | 23 | $2.39M |
| Q2 2025 | 23 | $3.07M |
| Q1 2025 | 26 | $3.78M |
| Q4 2024 | 26 | $6.83M |
| Q3 2024 | 22 | $5.50M |
| Q2 2024 | 28 | $8.48M |
| Q1 2024 | 24 | $10.8M |
| Q4 2023 | 20 | $4.36M |
| Q3 2023 | 21 | $3.66M |
| Q2 2023 | 19 | $2.78M |
| Q1 2023 | 18 | $3.77M |
| Q4 2022 | 25 | $521.3K |
| Q3 2022 | 27 | $1.11M |
| Q2 2022 | 34 | $1.52M |
| Q1 2022 | 40 | $4.50M |
| Q4 2021 | 41 | $10.4M |
| Q3 2021 | 39 | $25.6M |
| Q2 2021 | 50 | $31.9M |
| Q1 2021 | 67 | $45.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Aprea Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 3 | $14 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5 | $24 | 0.00% | +1+25.0% | Added |
| Princeton Global Asset Management LLC | 100 | $470 | 0.00% | 00.0% | Unchanged |
| WealthCollab, LLC | 158 | $743 | 0.00% | +158 | New |
| Advisor Group Holdings, Inc. | 200 | $940 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 272 | $1.28K | 0.00% | +2+0.7% | Added |
| Tower Research Capital LLC (TRC) | 548 | $2.58K | 0.00% | −1,199−68.6% | Reduced |
| MB, Levis & Associates, LLC | 806 | $3.79K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 1,000 | $4.70K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,160 | $10.2K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,251 | $15.3K | 0.00% | +10.0% | Added |
| BlackRock Inc. | 8,504 | $40.0K | 0.00% | −726−7.9% | Reduced |
| Morgan Stanley | 17,218 | $80.9K | 0.00% | +2,656+18.2% | Added |
| Geode Capital Management, LLC | 17,473 | $82.2K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 34,688 | $163.0K | 0.00% | +7,347+26.9% | Added |
| Royal Bank of Canada | 44,025 | $207.0K | 0.00% | +43,708+13,788.0% | Added |
| Walleye Capital LLC | 80,000 | $376.0K | 0.01% | −2,356−2.9% | Reduced |
| Worth Venture Partners, LLC | 87,169 | $409.7K | 0.22% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 280,000 | $1.32M | 0.34% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 349,300 | $1.64M | 0.65% | 00.0% | Unchanged |
| Bull Oak Capital, LLC | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −25−100.0% | Sold out |